Detailed answers about NOVALGEN LIMITED, including incorporation, status, business activity, and accounts information.
When was NOVALGEN LIMITED founded?
NOVALGEN LIMITED was officially incorporated on 14 October 2018 and is registered under company number 11621264. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NOVALGEN LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NOVALGEN LIMITED?
NOVALGEN LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NOVALGEN LIMITED do?
NOVALGEN LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NOVALGEN LIMITED's registered address?
The registered office address of NOVALGEN LIMITED is ARGYLE HOUSE LEVEL 3 NORTHSIDE, JOEL STREET, NORTHWOOD HILLS, MIDDLESEX, ENGLAND, HA6 1NW. This is the official address filed with Companies House for legal and statutory correspondence.
Is NOVALGEN LIMITED financially stable?
The most recent accounts for NOVALGEN LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.
Has NOVALGEN LIMITED changed its name?
Yes, NOVALGEN LIMITED has had 1 previous name: IMMUNOCURE LIMITED (changed 6 November 2018).